Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT05298501
Other study ID # NOV-0300
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date April 5, 2022
Est. completion date July 8, 2022

Study information

Verified date March 2022
Source Novoic Limited
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of the study is to examine the properties of the Automatic Story Recall Test (ASRT) and its parallel variants, as well as letter fluency and category fluency cognitive tests. Tests will be completed in crowdsourced populations, to derive normative data, and examine test properties in demographically diverse and cognitively impaired participants recruited and tested online.


Description:

The AMYWEB study will validate speech tasks developed by NOVOIC in different population samples, including normative samples, samples recruited for enhanced demographic diversity, and participants with reported cognitive impairment. Participants will be research volunteers recruited online and via crowdsourcing platforms. Six rounds of recruitment will be completed, evaluating different parallel variants of the Automatic Story Recall Task (ASRT), and fluency tasks. During each recruitment round participants will complete a speech test battery and questionnaires during one assessment (Baseline). Speech tasks will be recorded and later analyzed on Novoic's technology platform. All assessments will be fully online and remote.


Recruitment information / eligibility

Status Terminated
Enrollment 1034
Est. completion date July 8, 2022
Est. primary completion date July 8, 2022
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - First language must be English - Residing in the USA - Willing to participate in a study investigating speech and dementia - Able to provide informed consent - Access to personal computing device that is capable of audio and video recording, and able to connect to the internet Since key research questions are focused primarily on older-age speech and cognition, initial recruitment will be focused on older adult age brackets, which may be extended to younger adulthood if the desired sample sizes are not attained. Exclusion Criteria: - No formal exclusion criteria will apply at the point of recruitment and testing. however, participants with a reported history of neurological conditions or head injury, and current depression will be excluded from normative data development.

Study Design


Intervention

Other:
No intervention/exposure
No interventions/exposures will be administered or evaluated

Locations

Country Name City State
United Kingdom Novoic Ltd London

Sponsors (1)

Lead Sponsor Collaborator
Novoic Limited

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Age, sex, and education adjusted normative scores for the Automatic Story Recall Task (ASRT) test variants derived via linear regression analysis. Participants will complete a story recall task (ASRT), which will be administered in triplets (3x stories) with immediate and delayed recall assessed.
Six different test phases, recruiting different participant samples, will be completed in which six parallel ASRT triplets will be separately evaluated.
Normative data will be generated for each test triplet.
Baseline
Secondary Normative data will be derived for shorter variants of the ASRT test battery derived via linear regression analysis. Age, sex, and education adjusted normative scores for shorter test batteries established in the same way as the primary outcome for each distinct ASRT story triplet, using data from: 1 immediate recall, 2 immediate recalls, 3 immediate recalls, 3 immediate + 1 delayed recall, 3 immediate + 2 delayed recalls. Baseline
Secondary Age, sex, and education adjusted normative scores for the category fluency task performance derived via linear regression analysis. During two of the study phases, participants will complete category fluency tests (participants will be asked to name as many Animals or Vegetables as they can within one minute). Baseline
Secondary Age, sex, and education adjusted normative scores for the letter fluency task performance derived via linear regression analysis. During two of the study phases, participants will complete letter fluency tests (participants will be asked to say as many words as they can think of beginning with the letters F or S). Baseline
Secondary The effect of demographic differences on task performance will be evaluated via linear regression analysis. The effects of age, sex, education and ethnicity on cognitive outcome measures will be evaluated for all cognitive tasks separately. Baseline
Secondary Demographic and cultural biases will be examined via group or pairwise comparison of transcription error rate and scoring errors on a simple reading task. In data from a simple reading task evaluated in phases 1 and 2 of the study, transcription errors and automated scoring metrics will be evaluated alongside key demographic variables to test for cultural and demographic biases in automated transcription and scoring. Baseline
Secondary Performance differences in parallel ASRT variant tasks will be examined via task-wise comparison. The distribution of test scores across parallel ASRT variants will be evaluated. Baseline
Secondary Area under the curve (AUC) of the receiver operating characteristic (ROC) curve of the binary classifier distinguishing between the MCI sample and the normative sample using as input the speech elicited during cognitive tasks. Case control comparison of task performance between participants with AMYWEB-MCI and the AMYWEB-Normative population Baseline
Secondary Area under the curve (AUC) of the receiver operating characteristic (ROC) curve of the binary classifier distinguishing between depressed and non-depressed participants using as input the speech elicited during cognitive tasks. All participants will complete the Participant Health Questionnaire (PHQ-8) self-report measure, alongside cognitive assessment. Participants will be separated into low depressive symptomatology (PHQ-8 scores<10), and high depressive symptomatology (PHQ-8 score>=10) groups. Baseline
Secondary The agreement between the PHQ-8 and the corresponding regression model predicting depressive symptomatology from speech data elicited during tasks will be evaluated. All participants will complete the Participant Health Questionnaire (PHQ-8) self-report measure, alongside cognitive assessment.
A continuous predictor of PHQ-8 score from speech data will be derived and covariation with continuous PHQ-8 scores will be evaluated.
Baseline
See also
  Status Clinical Trial Phase
Completed NCT04513106 - Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial N/A
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Active, not recruiting NCT03167840 - Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment N/A
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Not yet recruiting NCT05041790 - A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment Phase 4
Recruiting NCT04121156 - High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment N/A
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Completed NCT02774083 - Cognitive Training Using Feuerstein Instrumental Enrichment N/A
Completed NCT01315639 - New Biomarker for Alzheimer's Disease Diagnostic N/A
Enrolling by invitation NCT06023446 - Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
Completed NCT04567745 - Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers Phase 1
Recruiting NCT05579236 - Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
Completed NCT03583879 - Using Gait Robotics to Improve Symptoms of Parkinson's Disease N/A
Terminated NCT02503501 - Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease Phase 2
Not yet recruiting NCT03740178 - Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) Phase 1
Active, not recruiting NCT05204940 - Longitudinal Observational Biomarker Study
Recruiting NCT02663531 - Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Recruiting NCT03507192 - Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia. N/A